Use of Checkpoint Inhibitors for Metastatic Urothelial Cancer

Use of Checkpoint Inhibitors for Metastatic Urothelial Cancer

User Photo
AnnualMeeting2017

3 years
509 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Steven E. Benner, MD, Senior Vice President and Global Therapeutic Head for Oncology at Astellas Oncology the future of treatment for metastatic urothelial cancer at the 2017 ASCO Annual Meeting in Chicago, IL.
Up Next Autoplay